Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways. Journal of Carcinogenesis, [S. l.], v. 5, n. 1, 2006. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/227. Acesso em: 7 dec. 2025.